Now let me write the final consolidated review.

## Summary

The paper introduces Constrained Mass Transport (CMT), a variational framework for learning Boltzmann generators that constructs intermediate densities under constraints on both the KL divergence (trust-region) and entropy decay between successive steps. Theoretically, CMT derives analytical solutions for the optimal intermediate densities under each constraint (Propositions 2.1–2.3) and connects them to geometric, tempered, and geometric-tempered annealing paths (Theorem 2.4). Practically, it instantiates the framework with normalizing flows trained via importance-weighted forward KL minimization. Empirically, CMT shows consistent improvement over FAB and TA-BG across four molecular systems, with the strongest gains on the largest system (ELIL tetrapeptide, d=219), which the paper introduces as a new benchmark.

## Strengths

1. **Clean theoretical derivation connecting constrained optimization to annealing paths (Section 2, Propositions 2.1–2.3, Theorem 2.4).** The paper rigorously derives analytical solutions for optimal intermediate densities under trust-region, entropy, and combined constraints, and shows how these induce specific annealing paths. The connection between the trust-region constraint (adapted from RL) and the geometric annealing path is established with clear mathematical reasoning. This is the paper's primary intellectual contribution.

2. **Convincing ablation study isolating the contribution of each constraint (Section 5.2, Figures 2–3).** On alanine hexapeptide, the paper systematically disables each constraint and shows that only the combined (geometric-tempered) variant avoids both mode collapse and unstable training. Figure 2a (entropy decay over training) and Figure 2b (ESS between successive intermediate densities) provide direct causal evidence for the mechanism the paper claims. This is the strongest empirical evidence in the paper.

3. **Consistent directional improvement across all four molecular systems (Table 1).** CMT achieves the best or tied-best EUBO on all four systems and the best ESS on all four. While the margins are modest on smaller systems (dipeptide: 97.69% vs 95.76%), they widen substantially on the larger ones (ELIL: 26.06% vs 13.75%). The monotonic direction across methods and metrics lends credibility to the claim that the framework is genuinely beneficial.

## Weaknesses

### Fatal
None.

### Major

1. **The "2.5× higher effective sample size" claim in the abstract and conclusion is not supported by the paper's own data.** Against the strongest energy-based competitor (TA-BG), the ESS ratios from Table 1 are: alanine dipeptide 1.02×, alanine tetrapeptide 1.04×, alanine hexapeptide 1.63×, ELIL tetrapeptide 1.90×. None exceed 2×, let alone 2.5×. Against FAB, the ratios are 1.03×, 1.08×, 2.04×, and 3.61× — so the 2.5× threshold is crossed only on a single comparison (ELIL vs FAB). The results section (Section 5.2) more accurately states "approximately twice the ESS of competing approaches." The abstract and conclusion should be revised to match what the evidence actually shows. This is a material overstatement of the paper's headline result.

2. **The claim that CMT "outperforms the baselines" across "all systems and metrics" (Section 5.2, line 237) is factually contradicted by the paper's own Table 1.** On ELIL tetrapeptide, TA-BG achieves a Ramachandran TV distance of 2.54×10⁻² (bolded as best) while CMT achieves 3.13×10⁻² — TA-BG is strictly better on this metric. The paper's general statement is false, and this exception is not discussed anywhere in the text. This needs correction and honest discussion of where baselines remain competitive.

### Minor

3. **The practical algorithm inherits the theory's guarantees only approximately, and the gap between the exact analytical densities and the learned flow approximations is not analyzed.** The analytical solutions in Section 2 describe optimal densities over *all* probability measures, but in practice (Section 3) these are approximated by normalizing flows via importance-weighted forward KL minimization. The theoretical properties (bounded KL divergence, controlled entropy decay) are guaranteed for the exact q_i but not for the learned approximations \hat{q}_i. The ablation study (Figure 2) tracks entropy and inter-ESS for the learned approximations, which partly addresses this, but the paper never quantifies how faithfully the learned densities respect the constraints — e.g., whether D_KL(\hat{q}_{i+1} \|\hat{q}_i) stays close to ε_tr. The paper should acknowledge this gap more precisely.

4. **The "extra degree of freedom" from the entropy constraint (line 28) is more about schedule flexibility than a structurally different path.** Both the trust-region-only solution (Proposition 2.1) and the combined solution (Proposition 2.3) yield the same functional form: a geometric mixture q_{i+1} ∝ q_i^a \tilde{p}^a, where a = 1/(1+λ) or a = 1/(1+λ+η) respectively. The entropy constraint changes how the schedule is determined (two Lagrange multipliers instead of one) but does not enable a fundamentally different interpolation mechanism. The paper should clarify this.

5. **TA-BG on ELIL tetrapeptide had only 2 successful runs out of 4 (Table 1 caption), so the comparison on this system is based on half the data.** While the paper discloses this, the Ram TV advantage of TA-BG on ELIL should be interpreted with caution given the reduced statistical basis. The paper does not discuss this caveat.

### Trivial
None.

## Nice-to-Haves

- The paper could provide a brief empirical characterization of the ELIL tetrapeptide benchmark beyond dimensionality and side-chain complexity, as the value of a new benchmark depends partly on what known challenges it presents (number of modes, barrier heights, etc.).
- A systematic quantification of how the learned \hat{q}_i deviate from the constraint bounds (e.g., tracking actual D_KL and entropy gap for the learned densities) would strengthen the connection between theory and practice.

## Removed Points

- **"Claim about trust-region constraining importance weight variance deferred to Appendix C.3 makes it impossible to evaluate from the main paper"**: The appendix is stripped by the parser; this material exists in the original submission per guidelines.
- **"Fixed number of annealing steps instead of constraint-based stopping"**: The paper explicitly justifies this choice for fair computational budgeting (line 223).
- **"Forward KL baseline has a data advantage making comparison uneven"**: The paper marks forward KL as "not directly comparable" in the table caption — this is properly handled.
- **"ELIL tetrapeptide lacks characterization"**: The paper defers full details to Appendix D.2, which is standard practice and the appendix is stripped.
- **"Missing discussion of Ram TV on ELIL"**: Subsumed by Major weakness #2.
- **"Equation (16) may have an exponent mismatch"**: Could be a parser artifact or typo — the appendix likely contains the full derivation. This is too uncertain to include as a confirmed weakness without access to the appendix.

## Novel Insights

None beyond the paper's own contributions. The main insight — that constraining both KL divergence and entropy between successive variational densities yields improved annealing paths for Boltzmann generators — is already well articulated in the paper. The reviews do not surface any genuinely novel observation that the paper itself misses.

## Suggestions

1. Revise the abstract and conclusion: replace "more than 2.5× higher ESS" with precise ranges (e.g., "up to 1.9× higher ESS than TA-BG and over 3.6× higher than FAB on the largest system, with consistent though smaller gains on smaller systems").
2. Remove or qualify the "across all systems and metrics" claim in Section 5.2. Acknowledge and discuss the ELIL Ram TV result where TA-BG outperforms CMT.
3. Add a brief analysis (even in the main paper) quantifying how well the learned \hat{q}_i respect the theoretical constraints — e.g., actual D_KL(\hat{q}_{i+1} \|\hat{q}_i) vs ε_tr, and actual entropy decay vs ε_ent.

## Score and Decision

The paper presents a theoretically sound method with a clean connection between constrained optimization and annealing paths, and provides convincing empirical evidence (especially the ablation study) that the approach works. The core contribution is real and practically useful. However, the paper oversells its results in two verifiable ways — the "2.5× higher ESS" claim and the "across all systems and metrics" claim — which affect its credibility. These are fixable with honest revision. On balance, the underlying science is strong enough that the paper should be accepted pending correction of the overstated claims.

MY FINAL SCORE: <score>6</score>
MY FINAL DECISION: <decision>Accept</decision>